ZA909768B - Piperidine derivatives the process for the preparation thereof and the pharmaceutical compositions containing them - Google Patents
Piperidine derivatives the process for the preparation thereof and the pharmaceutical compositions containing themInfo
- Publication number
- ZA909768B ZA909768B ZA909768A ZA909768A ZA909768B ZA 909768 B ZA909768 B ZA 909768B ZA 909768 A ZA909768 A ZA 909768A ZA 909768 A ZA909768 A ZA 909768A ZA 909768 B ZA909768 B ZA 909768B
- Authority
- ZA
- South Africa
- Prior art keywords
- image
- pathology
- piperidine derivatives
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 239000005864 Sulphur Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000003859 lipid peroxidation Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000006439 vascular pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8916384A FR2655649B1 (fr) | 1989-12-12 | 1989-12-12 | Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA909768B true ZA909768B (en) | 1991-09-25 |
Family
ID=9388394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA909768A ZA909768B (en) | 1989-12-12 | 1990-12-05 | Piperidine derivatives the process for the preparation thereof and the pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5126356A (de) |
| EP (1) | EP0433167B1 (de) |
| JP (1) | JPH07100695B2 (de) |
| AT (1) | ATE102186T1 (de) |
| AU (1) | AU629076B2 (de) |
| CA (1) | CA2031839A1 (de) |
| DE (1) | DE69007045T2 (de) |
| DK (1) | DK0433167T3 (de) |
| ES (1) | ES2052217T3 (de) |
| FR (1) | FR2655649B1 (de) |
| IE (1) | IE66909B1 (de) |
| NZ (1) | NZ236231A (de) |
| OA (1) | OA09473A (de) |
| PT (1) | PT96156B (de) |
| ZA (1) | ZA909768B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU214331B (hu) * | 1992-06-17 | 1998-03-02 | Gyógyszerkutató Intézet Kft. | Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| WO2003099788A1 (en) * | 2002-05-28 | 2003-12-04 | Nippon Chemiphar Co., Ltd. | Piperidine derivatives |
| WO2005030721A1 (ja) * | 2003-09-30 | 2005-04-07 | Nippon Chemiphar Co., Ltd. | ピペリジン誘導体 |
| WO2017004485A1 (en) | 2015-07-02 | 2017-01-05 | Raptor Pharmaceuticals Inc. | Ado-resistant cysteamine analogs and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
| FR2514353A2 (fr) * | 1980-04-28 | 1983-04-15 | Synthelabo | Derives de piperidine et leur application en therapeutique |
| ATE13425T1 (de) * | 1981-10-15 | 1985-06-15 | Synthelabo | Piperidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
| US4529730A (en) * | 1981-10-21 | 1985-07-16 | Synthelabo | Piperidine derivatives, their preparation and pharmaceutical compositions containing them |
| GB8321157D0 (en) * | 1983-08-05 | 1983-09-07 | Fordonal Sa | Piperidine derivatives |
| ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
-
1989
- 1989-12-12 FR FR8916384A patent/FR2655649B1/fr not_active Expired - Fee Related
-
1990
- 1990-11-27 NZ NZ236231A patent/NZ236231A/en unknown
- 1990-12-05 ZA ZA909768A patent/ZA909768B/xx unknown
- 1990-12-07 CA CA002031839A patent/CA2031839A1/fr not_active Abandoned
- 1990-12-10 IE IE443490A patent/IE66909B1/en not_active IP Right Cessation
- 1990-12-11 AU AU67936/90A patent/AU629076B2/en not_active Ceased
- 1990-12-11 PT PT96156A patent/PT96156B/pt not_active IP Right Cessation
- 1990-12-11 US US07/625,422 patent/US5126356A/en not_active Expired - Fee Related
- 1990-12-12 OA OA59915A patent/OA09473A/xx unknown
- 1990-12-12 DK DK90403537.5T patent/DK0433167T3/da active
- 1990-12-12 EP EP90403537A patent/EP0433167B1/de not_active Expired - Lifetime
- 1990-12-12 AT AT90403537T patent/ATE102186T1/de active
- 1990-12-12 DE DE69007045T patent/DE69007045T2/de not_active Expired - Fee Related
- 1990-12-12 ES ES90403537T patent/ES2052217T3/es not_active Expired - Lifetime
- 1990-12-12 JP JP2419227A patent/JPH07100695B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69007045D1 (de) | 1994-04-07 |
| IE904434A1 (en) | 1991-06-19 |
| AU6793690A (en) | 1991-06-20 |
| JPH06340626A (ja) | 1994-12-13 |
| FR2655649A1 (fr) | 1991-06-14 |
| OA09473A (fr) | 1992-11-15 |
| NZ236231A (en) | 1992-07-28 |
| AU629076B2 (en) | 1992-09-24 |
| JPH07100695B2 (ja) | 1995-11-01 |
| DE69007045T2 (de) | 1994-08-04 |
| PT96156A (pt) | 1991-09-30 |
| FR2655649B1 (fr) | 1994-07-08 |
| CA2031839A1 (fr) | 1991-06-13 |
| DK0433167T3 (da) | 1994-05-02 |
| PT96156B (pt) | 1998-05-29 |
| ES2052217T3 (es) | 1994-07-01 |
| EP0433167B1 (de) | 1994-03-02 |
| US5126356A (en) | 1992-06-30 |
| ATE102186T1 (de) | 1994-03-15 |
| EP0433167A1 (de) | 1991-06-19 |
| IE66909B1 (en) | 1996-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE17728T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE111912T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate. | |
| KR900016098A (ko) | 카페인산의 유도체 및 이를 함유하는 약제학적 조성물 | |
| ATE6645T1 (de) | Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| ZA909768B (en) | Piperidine derivatives the process for the preparation thereof and the pharmaceutical compositions containing them | |
| ZA917107B (en) | Spiro(4.5)decane compounds,a process for the preparation thereof and pharmaceutical compositions containing them | |
| ATE116647T1 (de) | Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| IL85768A0 (en) | Benzoxazine derivatives,their preparation and pharmaceutical compositions containing them | |
| DE68922053D1 (de) | Pyridoindolderivate und Verfahren zu ihrer Herstellung. | |
| ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE1066T1 (de) | Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| SE8603589L (sv) | Metylendioxifenantren- och stilbenderivat | |
| SE8400629L (sv) | Basiska oximetrar | |
| ATE104976T1 (de) | Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| PT93904A (pt) | Processo para a preparacao de novos derivados benzotiazolinonicos e de composicoes farmaceuticas que os contem | |
| ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| ZA909557B (en) | Substituted benzothiazolinones,process for preparing these and pharmaceutical compositions containing them | |
| ATE52509T1 (de) | Thiazolidinderivate und verfahren zu ihrer herstellung. | |
| DE3674250D1 (de) | Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung. | |
| PT97885A (pt) | Processo para a preparacao de derivados da {(1-aril-2-pirrolidinil)-metil-piperazina e de composicoes farmaceuticas que os contem | |
| HU9401978D0 (en) | Process for producing pharmaceutical compositions containing beta-naphtoquinone derivatives or salts thereof for inhibiting blood platelet aggregation | |
| PT79486B (fr) | Procede de preparation de nouveaux derives de thieno<2,3-b>pyrrole et de compositions pharmaceutiques les contenant | |
| ATE3295T1 (de) | Clavulansaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| DE3482857D1 (de) | 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die bekaempfung von herz- und gefaesskrankheiten. |